Trending Now
- “If Edappadi Palaniswami permits, a thousand young members from the Virudhunagar district AIADMK are prepared to take up arms and engage in battle under my command.” – Former AIADMK Minister Rajendra Balaji
- “India is ready to deal with any counter-attack by Pakistan” – Wing Commander Vyomika Singh
- Central govt orders extension of CBI Director Praveen Sood’s tenure for another year
Businesswire
Taro Annual Report on Form 20-F Available
June 25, 2018
Taro Pharmaceutical Industries Ltd. (NYSE:TARO, “Taro”) announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2018, filed with the Securities and Exchange Commission (the “SEC”), is available within the Investor Relations section of Taro’s website at www.taro.com.
Hard copies of the report may be ordered free of charge by sending requests to:
Taro Pharmaceuticals U.S.A., Inc.
3 Skyline Drive
Hawthorne, NY 10532
attention: William J. Coote or
via email to [email protected]
Additionally, the report may be accessed on the SEC’s website at www.sec.gov.
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit Taro’s website at www.taro.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180622005431/en/
Source: Businesswire
